Clin2
NCT07219368Likely a fitRecruiting

Testing a new drug (MT-201) safety in healthy adults

Healthy Volunteer

This trial tests a new medicine called MT-201 to see if it is safe and how the body handles it. It is for healthy volunteers aged 19 to 55 who are willing to follow study rules.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
72 people
Ages
19 years to 55 years
Study type
Interventional

Who can take part

  • Age 19 to 55 years old
  • In good general health
  • If you can get pregnant, you must be postmenopausal or surgically sterile
  • Men must use condoms and not donate sperm during the study
  • No other health conditions or recent use of other study drugs
  • No history of drug or alcohol abuse in the last 2 years and no smoking in the last 3 months

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07776782Recruiting· Phase 1
Testing a new drug with infliximab in healthy volunteers

This study tests a new experimental drug called MT-201 when given with an existing medicine (infliximab) to healthy people. It helps doctors learn how the drugs work in the body and whether they are safe.

San Diego, California
NCT07423299Recruiting· Phase 1
First human safety study of MT-251 in healthy volunteers

This is the first human study of a new medication called MT-251. It is a safety study, so healthy volunteers are given either a single dose or multiple doses of the drug to see how the body handles it and if there are any side effects.

San Diego, California
NCT07235163Recruiting· Phase 1
Testing a new medicine in healthy adults

This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.

Brussels, Bruxelles-capitale, Région de
NCT06324604Recruiting· Phase 1
Safety study of MTX-101 in healthy adults

This trial tests a new drug called MTX-101 in healthy volunteers to see if it is safe and how the body processes it. It helps determine the right dose before testing in patients with certain conditions.

Heidelberg, Victoria
NCT07748026Not yet recruiting· Phase 1
Testing a new medicine in healthy adults

This study tests a new medicine, ART105, in healthy adults to see if it is safe and how the body handles it. It is an early-stage trial, so it may not directly help you, but you would be contributing to medical research.

NCT07182552Enrolling by invitation· Phase 1
Testing a new drug NTB003 in healthy volunteers

This early-phase trial tests the safety of a new drug called NTB003 in healthy people. It looks at how the drug moves through the body and affects it, which is a first step toward possibly treating certain conditions.

Beijing

Hear when a new Healthy Volunteer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.